Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In collaboration with WWARN and in association with WHO an extensive review of antimalarial toxicity has been completed, focussing on DHA-piperaquine initially (and showing safety), and now extending to other antimalarial drugs.

The effects of malaria and fever on the ECG have been characterised and approaches for rate correction for the QT interval assessed based on the largest available databases.